All Stories

  1. Analysis of Genetic Variants in SCN1A, SCN2A, KCNK18, TRPA1 and STX1A as a Possible Marker of Migraine
  2. Genetic Variants and Oxidative Stress in Alzheimer’s Disease
  3. Genetic Editing and Pharmacogenetics in Current And Future Therapy Of Neurocognitive Disorders
  4. The Role of Vitamin D Receptor Gene Polymorphisms in Thyroid-Associated Orbitopathy
  5. Primary progressive multiple sclerosis and neurofibromatosis type 1
  6. APOE genetic variants and apoE, miR-107 and miR-650 levels in Alzheimer’s disease
  7. Longrange PCR-based next-generation sequencing in pharmacokinetics and pharmacodynamics study of propofol among patients under general anaesthesia
  8. Aging and Neurological Diseases
  9. [P3-235]: APOE VARIANTS, TOMM40 RS10524523 POLYMORPHISM, AND FAMILY HISTORY OF ALZHEIMER's DISEASE
  10. The effect of UGT1A9, CYP2B6 and CYP2C9 genes polymorphism on individual differences in propofol pharmacokinetics among Polish patients undergoing general anaesthesia
  11. Normal Aging and Dementia
  12. Molecular Basis of Familial and Sporadic Alzheimer's Disease
  13. Molecular factors in migraine
  14. P2-047: Expression of microrna-138, microrna-185, and apoptotic factors in the brain of double transgenic mouse model of Alzheimer's disease
  15. Activated Caspase-3 and Neurodegeneration and Synaptic Plasticity in Alzheimer’s Disease
  16. P3-124: APOLIPOPROTEIN E GENOTYPE AND OXIDATIVE STRESS IN PERIPHERAL LYMPHOCYTES OF PATIENTS WITH ALZHEIMER'S DISEASE
  17. Molecular Effects of L-dopa Therapy in Parkinson’s Disease
  18. Polymorphism of the COMT, MAO, DAT, NET and 5-HTT Genes, and Biogenic Amines in Parkinson’s Disease
  19. Original article Mutations in the exon 7 of Trp53 gene and the level of p53 protein in double transgenic mouse model of Alzheimer’s disease
  20. Mutations of TP53 Gene and Oxidative Stress in Alzheimer’s Disease Patients
  21. Homocysteine and asymmetric dimethylarginine concentrations in the plasma of Alzheimer’s disease patients with varying degrees of dementia